We are updating our recovery analysis on U.S. medical products manufacturer ConvaTec Inc. (ConvaTec), in conjunction with our annual review of the company. Standard & Poor's Ratings Services' simulated default scenario contemplates a default in 2015, stemming from a combination of increased competition, an inability to bring new products to market in a timely manner, and reduced reimbursement rates. We believe that ConvaTec would reorganize in the event of a default, given its global presence and its diverse portfolio covering ostomy care, wound therapeutics, and skin care. (For Standard & Poor's recovery rating methodology, see "Criteria Guidelines For Recovery Ratings," published Aug. 10, 2009, on RatingsDirect.) ConvaTec Healthcare B S.- r.l., a Luxembourg-organized company (Holdings), along with ConvaTec Healthcare D...
Companies mentioned in this report are: ConvaTec Inc.,ConvaTec Healthcare D S.?.r.l.,ConvaTec Healthcare B S.?.r.l.,ConvaTec Healthcare E S.A.
Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.
Research Type: Full Analysis